Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2020 | PTEN expression as a complementary biomarker

Nicola Fusco • 16 May 2020
ESMO Breast 2020
Breast Cancer

Nicola Fusco, MD, Istituto Europeo di Oncologia, Milan, Italy, discusses PTEN expression as a complementary biomarker for mismatch repair testing in breast cancer (BC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Nicola Fusco

1:40
Future directions of liquid biopsy for breast cancer
Nicola Fusco • 25 Oct 2022
1:50
Liquid biopsy for breast cancer
Nicola Fusco • 25 Oct 2022
3:22
PTEN protein and gene expression as a biomarker in breast cancer
Nicola Fusco • 13 May 2021
17:02
The right biomarker for the right patient
Nicola Fusco • 13 May 2020

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals